Amyris, Wacker to Develop Precision-Fermented Ingredients for Personal Care

Why It Matters

The partnership accelerates the supply of sustainable, high‑performance ingredients, helping personal‑care brands meet growing consumer demand for eco‑friendly formulations. It also demonstrates how legacy chemicals firms can leverage biotech to stay competitive in a rapidly greening market.

Key Takeaways

• Wacker and Amyris partner to create bio‑based personal‑care ingredients
• Amyris added two 80 m³ fermentation lines in Brazil
• Collaboration merges Wacker’s formulation know‑how with Amyris’s biotech
• New Belnexrt brand showcases renewable ingredients at In‑Cosmetics
• Partnership targets sustainable alternatives to palm oil and petro‑chemicals

Pulse Analysis

The alliance between Wacker and Amyris reflects a broader industry pivot toward renewable chemistry. Amyris’s recent expansion in Brazil, featuring two 80 m³ precision‑fermentation reactors, dramatically increases its ability to produce custom molecules at scale. This capacity surge not only shortens time‑to‑market for biotech‑derived actives but also lowers production costs, making bio‑based alternatives more attractive to large‑volume personal‑care manufacturers.

Wacker brings a century‑old legacy of formulation science and a global network of testing centers to the table. By integrating Amyris’s micro‑bial platforms with its own expertise in cyclodextrin, cysteine, and other functional chemistries, Wacker can translate raw biotech outputs into ready‑to‑use ingredients that meet performance expectations. The joint development pipeline focuses on replacing traditional palm‑oil and mineral‑oil components with fermented fats, proteins, and pigments that deliver comparable texture, stability, and sensory attributes.

For brands, the collaboration promises a faster route to market for sustainable formulations, a key differentiator as consumers increasingly scrutinize ingredient origins. Wacker’s launch of the Belnexrt line at In‑Cosmetics underscores the commercial momentum behind these efforts, offering formulators a portfolio that spans silicon‑based to fully plant‑derived actives. As regulatory pressure mounts and supply‑chain resilience becomes paramount, the Wacker‑Amyris partnership positions both companies to capture a growing share of the eco‑focused personal‑care market.